Developer docs
API playgroundTry for free, no card

Search company profiles

Protein Metrics

Full company profile

uuid0008hwz

Namestring
Protein Metrics
Legal namestring
Protein Metrics
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Protein Metrics is a vendor-neutral mass spectrometry software company specializing in biotherapeutic protein characterization, founded in 2011 and based in Cupertino, California. The company provides a platform-plus-modules architecture consisting of three core products: Byonic (a high-sensitivity MS/MS search engine for peptide and protein identification validated in independent benchmarks), Byos (desktop software for protein characterization supporting intact mass, peptide, oligonucleotide, HDX, de novo sequencing, reconstruction, and chromatogram workflows), and Byosphere (cloud-based enterprise platform for data management, analysis, templated reporting, dashboards, and team-wide collaboration). The software processes data from all major mass spectrometry instrument vendors and is differentiated by proprietary algorithms including the Parsimonious Deconvolution Algorithm and an automated de novo antibody sequencing algorithm.

The company serves biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and academic research institutions globally. Named enterprise customers include Roche, Sanofi, Genentech, Pfizer, Novartis, Janssen, Bristol-Myers Squibb, Amgen, Regeneron, GSK, AstraZeneca, Lonza, Boehringer Ingelheim, and Fujifilm Diosynth Biotechnologies, alongside academic institutions such as Stanford, Oxford, and University of Tokyo. Revenue is generated through enterprise software licensing (subscription/recurring) with a direct field sales motion; the company offers free trials for Byos and Byonic while enterprise Byosphere engagements are routed through Contact Sales. Distribution is augmented by an integration with Thermo Fisher Scientific's Proteome Discoverer platform. Protein Metrics operates as a subsidiary of Dotmatics, a diversified scientific R&D software platform, and holds ISO 27001 certification with GxP-ready compliance features.

The business is small (11-50 employees) and private, with the only disclosed funding being a $950K seed round in 2014, implying capital-efficient operation and likely funding through the Dotmatics parent or operating cash flow. The product cadence — nine sequential releases between March 2024 and April 2026 — indicates active R&D investment, while the integration into the Dotmatics portfolio positions the company as the proteomics layer within a broader enterprise R&D software stack.

Short descriptiontext

Protein Metrics provides vendor-neutral mass spectrometry software for biotherapeutic protein characterization, serving biopharmaceutical companies, CDMOs, and academic research institutions with its Byos, Byonic, and Byosphere platforms as a subsidiary of Dotmatics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCupertino, United States
HQ citystring
Cupertino
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
mass spectrometry software, biotherapeutic protein analysis, proteomics data analysis, protein characterization software, biopharmaceutical analytics
Industry2 codes
1Proteomics & Mass Spectrometry Services
CodeHLAGANABPrimaryYes
2Proteomics & Biomarker Analytical Testing
CodeHLAGADAGPrimaryNo
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518210
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Proteomics / Mass Spectrometry Software
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Software Licenses
TypeSubscription Recurring
Description

Protein Metrics generates revenue through software licensing of Byos (desktop), Byonic (MS/MS search engine), and Byosphere (cloud enterprise platform). The company offers free trials for initial customer acquisition, with enterprise sales motion suggesting subscription or perpetual licensing models for pharmaceutical and biotech customers.

proteinmetrics.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details1 tier
1Free Trial available for Byos and Byonic
ModelFreemiumBilling cadenceMonthly
Notes

The company offers Try for Free options for Byos and Byonic software. Enterprise pricing requires Contact Sales / Request Demo engagement.

proteinmetrics.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Byosphere
Description

Cloud enterprise software platform for biotherapeutic mass spectrometry data management, analysis, and reporting.

proteinmetrics.com
+2 more records
Core offering1 text field

Protein Metrics provides vendor-neutral mass spectrometry data analysis software for biotherapeutic protein characterization and quantification. Its portfolio includes Byos (desktop analysis software), Byonic (MS/MS search engine), and Byosphere (cloud enterprise platform), sold to pharmaceutical, biotechnology, CDMO, and academic customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Deconvolution algorithm minimizes artifacts and harmonics for highly accurate mass determination
+5 more records
Product overview1 text field

Protein Metrics offers a platform-plus-modules product architecture centered on three core software products: Byonic (full MS/MS search engine for peptide and protein identification), Byos (desktop software for comprehensive protein characterization with multiple workflow modules), and Byosphere (cloud enterprise platform for data management, analysis, and collaboration). The product portfolio includes specialized workflow modules for intact mass analysis, oligonucleotide analysis, multi-protein quantitation, peptide-level analysis, chromatogram analysis, de novo sequencing, reconstruction, and higher-order structure analysis. Additional capabilities include adaptive image compression for digital pathology and dashboard/analytics tools for data visualization and system suitability monitoring. The platform is vendor-neutral, supporting data from all major mass spectrometry platforms.

Product and service2 records
1Byos
CategoryMass Spectrometry Analysis Software
Description

Desktop software offering comprehensive mass spectrometry analysis workflows for robust biotherapeutic protein characterization and reporting, supporting intact, peptide, chromatogram, oligo, and multi-protein workflows with automated analysis and templated reporting.

2Byonic
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading CDMO Lonza uses Byosphere to overcome bottlenecks in mass spectrometry and accelerate biologics development. Lonza shared how Byosphere enables high-throughput processing, automated workflows, and faster decision-making—empowering analysis of complex formats like bispecifics and multi-chain constructs. Heather Oakes from Lonza presented at Protein Metrics webinar on their CDMO mass spectrometry approach.

Strategic tierCoreTypeTechnology or Integration
Description

Protein Metrics provides Proteome Discoverer nodes that integrate Preview/Byonic into Thermo Fisher Scientific's Proteome Discoverer platform, enabling seamless workflow within the widely-used proteomics software environment.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Provides biopharma R&D informatics including Expressionist for MS-based protein characterization and Screener for assay data. Competes head-to-head with Byos/Byosphere in enterprise biopharma workflows with comparable per-customer contract economics.

TypeBroad incumbent
Description

Ships Proteome Discoverer and Chromeleon as native proteomics/mass spec software for its instrument installed base. Also a Protein Metrics integration partner via Preview/Byonic nodes, creating a coopetitive relationship where Thermo both distributes and competes with Protein Metrics.

TypeBroad incumbent
Description

Offers MassLynx and Progenesis QI for proteomics/metabolomics, bundled with its LC-MS instruments. Direct competitor for biotherapeutic characterization software, especially in intact mass and peptide mapping workflows.

4SCIEX
TypeBroad incumbent
Description

Provides BioPharmaView and SCIEX OS for biologics characterization on its mass spec instruments. Comparable in targeting biopharma analytical workflows with similar intact mass and peptide mapping use cases as Protein Metrics.

TypeBroad incumbent
Description

Offers ProteinScape, BioTools, and timsControl for proteomics and biotherapeutic characterization. Competes in the same biopharma MS software category with both standalone tools and instrument-bundled offerings.

TypeBroad incumbent
Description

Ships MassHunter and Spectrum Mill for LC-MS data analysis including biotherapeutic characterization. Comparable incumbents in mass spec vendor software competing for the same enterprise pharma accounts.

TypeOthers
Description

Parent company and adjacent platform owner of multiple scientific R&D software brands including Protein Metrics. Thematically adjacent as a scientific data management / ELN / informatics platform, but not a direct product competitor.

TypeEmerging player
Description

Specializes in analytical chemistry software including MS data interpretation (Mnova MS). An emerging specialist in molecular characterization tools that overlaps with Protein Metrics' analytical workflow footprint in pharma and academic settings.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers18 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Protein Metrics

Proteomics / Mass Spectrometry Softwareproteinmetrics.com

Protein Metrics provides vendor-neutral mass spectrometry software for biotherapeutic protein characterization, serving biopharmaceutical companies, CDMOs, and academic research institutions with its Byos, Byonic, and Byosphere platforms as a subsidiary of Dotmatics.

What Protein Metrics does

Protein Metrics is a vendor-neutral mass spectrometry software company specializing in biotherapeutic protein characterization, founded in 2011 and based in Cupertino, California. The company provides a platform-plus-modules architecture consisting of three core products: Byonic (a high-sensitivity MS/MS search engine for peptide and protein identification validated in independent benchmarks), Byos (desktop software for protein characterization supporting intact mass, peptide, oligonucleotide, HDX, de novo sequencing, reconstruction, and chromatogram workflows), and Byosphere (cloud-based enterprise platform for data management, analysis, templated reporting, dashboards, and team-wide collaboration). The software processes data from all major mass spectrometry instrument vendors and is differentiated by proprietary algorithms including the Parsimonious Deconvolution Algorithm and an automated de novo antibody sequencing algorithm.

The company serves biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and academic research institutions globally. Named enterprise customers include Roche, Sanofi, Genentech, Pfizer, Novartis, Janssen, Bristol-Myers Squibb, Amgen, Regeneron, GSK, AstraZeneca, Lonza, Boehringer Ingelheim, and Fujifilm Diosynth Biotechnologies, alongside academic institutions such as Stanford, Oxford, and University of Tokyo. Revenue is generated through enterprise software licensing (subscription/recurring) with a direct field sales motion; the company offers free trials for Byos and Byonic while enterprise Byosphere engagements are routed through Contact Sales. Distribution is augmented by an integration with Thermo Fisher Scientific's Proteome Discoverer platform. Protein Metrics operates as a subsidiary of Dotmatics, a diversified scientific R&D software platform, and holds ISO 27001 certification with GxP-ready compliance features.

The business is small (11-50 employees) and private, with the only disclosed funding being a $950K seed round in 2014, implying capital-efficient operation and likely funding through the Dotmatics parent or operating cash flow. The product cadence — nine sequential releases between March 2024 and April 2026 — indicates active R&D investment, while the integration into the Dotmatics portfolio positions the company as the proteomics layer within a broader enterprise R&D software stack.

Protein Metrics firmographics

Firmographics
Name
Protein Metrics
Legal name
Protein Metrics
Website
https://proteinmetrics.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Protein Metrics provides vendor-neutral mass spectrometry software for biotherapeutic protein characterization, serving biopharmaceutical companies, CDMOs, and academic research institutions with its Byos, Byonic, and Byosphere platforms as a subsidiary of Dotmatics.
Ownership category
akta.pro rank

Protein Metrics industry classification

Industry
Product category
Proteomics / Mass Spectrometry Software
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210)
SIC
Laboratory Analytical Instruments (3826)
akta.pro primary industry
Proteomics & Mass Spectrometry Services (HLAGANAB)
akta.pro secondary industry
Proteomics & Biomarker Analytical Testing (HLAGADAG)

Keywords

  • Mass spectrometry software
  • Biotherapeutic protein analysis
  • Proteomics data analysis
  • Protein characterization software
  • Biopharmaceutical analytics

Where Protein Metrics is headquartered

Location

Headquarters

HQ city
Cupertino
HQ country
United States
HQ region
North America

Markets served

Protein Metrics business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Software Licenses: Protein Metrics generates revenue through software licensing of Byos (desktop), Byonic (MS/MS search engine), and Byosphere (cloud enterprise platform). The company offers free trials for initial customer acquisition, with enterprise sales motion suggesting subscription or perpetual licensing models for pharmaceutical and biotech customers.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree Trial available for Byos and Byonic

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Protein Metrics product offering

Product offering

Core offering

Protein Metrics provides vendor-neutral mass spectrometry data analysis software for biotherapeutic protein characterization and quantification. Its portfolio includes Byos (desktop analysis software), Byonic (MS/MS search engine), and Byosphere (cloud enterprise platform), sold to pharmaceutical, biotechnology, CDMO, and academic customers.

Product overview

Protein Metrics offers a platform-plus-modules product architecture centered on three core software products: Byonic (full MS/MS search engine for peptide and protein identification), Byos (desktop software for comprehensive protein characterization with multiple workflow modules), and Byosphere (cloud enterprise platform for data management, analysis, and collaboration). The product portfolio includes specialized workflow modules for intact mass analysis, oligonucleotide analysis, multi-protein quantitation, peptide-level analysis, chromatogram analysis, de novo sequencing, reconstruction, and higher-order structure analysis. Additional capabilities include adaptive image compression for digital pathology and dashboard/analytics tools for data visualization and system suitability monitoring. The platform is vendor-neutral, supporting data from all major mass spectrometry platforms.

Differentiator

Problem solved

Functional benefit

Brands

  • Byosphere: Cloud enterprise software platform for biotherapeutic mass spectrometry data management, analysis, and reporting.
  • Byos
  • Byonic

Products and services

  • Byos Desktop software offering comprehensive mass spectrometry analysis workflows for robust biotherapeutic protein characterization and reporting, supporting intact, peptide, chromatogram, oligo, and multi-protein workflows with automated analysis and templated reporting.
  • Byonic

Quantifiable outcome

  • Deconvolution algorithm minimizes artifacts and harmonics for highly accurate mass determination
  • +5 more outcomes

Companies that use Protein Metrics

Customer profile

Named customers18 records

Segments3 records

Ideal customer profiles3 records

Protein Metrics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability3 records

Feature6 records

Protein Metrics partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • LonzacoreStrategic or Co-development PartnerLeading CDMO Lonza uses Byosphere to overcome bottlenecks in mass spectrometry and accelerate biologics development. Lonza shared how Byosphere enables high-throughput processing, automated workflows, and faster decision-making—empowering analysis of complex formats like bispecifics and multi-chain constructs. Heather Oakes from Lonza presented at Protein Metrics webinar on their CDMO mass spectrometry approach.
  • Thermo Fisher ScientificcoreTechnology or IntegrationProtein Metrics provides Proteome Discoverer nodes that integrate Preview/Byonic into Thermo Fisher Scientific's Proteome Discoverer platform, enabling seamless workflow within the widely-used proteomics software environment.

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

Protein Metrics competitors and assessment

Company assessment

Direct peers

  • Genedata: Provides biopharma R&D informatics including Expressionist for MS-based protein characterization and Screener for assay data. Competes head-to-head with Byos/Byosphere in enterprise biopharma workflows with comparable per-customer contract economics.

Broad incumbents

  • Thermo Fisher Scientific: Ships Proteome Discoverer and Chromeleon as native proteomics/mass spec software for its instrument installed base. Also a Protein Metrics integration partner via Preview/Byonic nodes, creating a coopetitive relationship where Thermo both distributes and competes with Protein Metrics.
  • Waters Corporation: Offers MassLynx and Progenesis QI for proteomics/metabolomics, bundled with its LC-MS instruments. Direct competitor for biotherapeutic characterization software, especially in intact mass and peptide mapping workflows.
  • SCIEX: Provides BioPharmaView and SCIEX OS for biologics characterization on its mass spec instruments. Comparable in targeting biopharma analytical workflows with similar intact mass and peptide mapping use cases as Protein Metrics.
  • Bruker: Offers ProteinScape, BioTools, and timsControl for proteomics and biotherapeutic characterization. Competes in the same biopharma MS software category with both standalone tools and instrument-bundled offerings.
  • Agilent Technologies: Ships MassHunter and Spectrum Mill for LC-MS data analysis including biotherapeutic characterization. Comparable incumbents in mass spec vendor software competing for the same enterprise pharma accounts.

Others

  • Dotmatics: Parent company and adjacent platform owner of multiple scientific R&D software brands including Protein Metrics. Thematically adjacent as a scientific data management / ELN / informatics platform, but not a direct product competitor.

Emerging players

  • Mestrelab Research: Specializes in analytical chemistry software including MS data interpretation (Mnova MS). An emerging specialist in molecular characterization tools that overlaps with Protein Metrics' analytical workflow footprint in pharma and academic settings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Protein Metrics compliance and trust

Trust signal

Compliance2 records

Protein Metrics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Protein Metrics leadership team

Management profile

Number of profiles

Profiles4 records

Protein Metrics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Protein Metrics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Protein Metrics

What does Protein Metrics do?

Protein Metrics provides vendor-neutral mass spectrometry data analysis software for biotherapeutic protein characterization and quantification. Its portfolio includes Byos (desktop analysis software), Byonic (MS/MS search engine), and Byosphere (cloud enterprise platform), sold to pharmaceutical, biotechnology, CDMO, and academic customers.

Is Protein Metrics a public or private company?

Protein Metrics is a private company. It is classified as corporate owned and is currently operating.

When was Protein Metrics founded?

Protein Metrics was founded in 2011. It employs 11 to 50 people.

Where is Protein Metrics based?

Protein Metrics is headquartered in Cupertino, United States, in the North America region.

How does Protein Metrics make money?

One revenue line is on record: software Licenses.

Who are Protein Metrics's main competitors?

Genedata is listed as a direct peer. Broad incumbents are Thermo Fisher Scientific, Waters Corporation, SCIEX, Bruker and Agilent Technologies. Dotmatics is listed as an others. Mestrelab Research is listed as an emerging player.

Does Protein Metrics have an API?

No public API is recorded for Protein Metrics.

What industry is Protein Metrics in?

Protein Metrics's product category is Proteomics / Mass Spectrometry Software. Its primary akta.pro industry code is HLAGANAB, Proteomics & Mass Spectrometry Services, with a secondary code of HLAGADAG, Proteomics & Biomarker Analytical Testing. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireThermo Fisher Scientific Collaborates with Protein Metrics to Optimize Mass Spectrometry Data Analysis for Biopharmaceutical and Proteomics ApplicationsThermo Fisher Scientific and Protein Metrics have entered into a non-exclusive co-marketing agreement to provide advanced mass spectrometry data processing and analysis capabilities for biopharmaceutical and proteomics applications. Under the collaboration, Thermo Fisher's Chromeleon CDS software will be integrated with Protein Metrics' Byos platform and Byosphere enterprise platform, enabling scientists to automate workflows and reduce processing time for mass spectrometry data. The partnership aims to help biopharmaceutical companies address challenges in analyzing complex analytical data with streamlined, compliance-ready tools.PR NewswireIntabio and Protein Metrics Launch Strategic PartnershipIntabio, Inc. and Protein Metrics Inc. announced on March 11, 2020 a co-development and co-marketing agreement to integrate Intabio's Blaze instrument system with Protein Metrics' Byos software suite into a unified platform for biopharmaceutical analysis. The combined Blaze-Byos platform will automate analysis of large protein structure and quality data sets, enabling critical drug development decisions months earlier than legacy approaches, with the Blaze system delivering 100 times the throughput of traditional methods. Both companies, headquartered in California's Silicon Valley, expect the integrated workflow to improve laboratory efficiency and reporting across the biopharmaceutical development pipeline.PR NewswireProtea announces new test methods for therapeutic antibodiesProtea Biosciences Group announced it has integrated its therapeutic antibody analytical methods with new software developed by partner Protein Metrics to automate detailed analysis of antibody structures, with results presented at the 65th American Society for Mass Spectrometry Conference in Indianapolis, Indiana. The new methods can identify molecular deviations such as shuffled disulfide bond arrangements, glycosylations, and post-translational modifications, as well as host cell protein impurities during recombinant protein production. Protea stated that researchers can now access a complete solution for therapeutic antibody production and analytical characterization through its partnerships with Protein Metrics and Proteos.